Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Florida?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Florida resident can legally obtain FDA approved peptides such as semaglutide and tirzepatide from any Florida-licensed prescriber, including by telehealth, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy that holds a Florida permit or a Florida nonresident pharmacy registration. Florida's telehealth statute (section 456.47) lets Florida-licensed, compact-licensed, and registered out-of-state practitioners evaluate and prescribe without a prior physical exam when the telehealth evaluation is sufficient to diagnose and treat and meets the in-person standard of practice. The statute bars telehealth prescribing of Schedule II controlled substances except in listed cases, and the Florida Board of Pharmacy regulates compounding under chapter 465 and rule chapter 64B16-27. Out-of-state pharmacies shipping compounded sterile injectables into Florida need an additional nonresident sterile compounding permit.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed
Compounded GLP-1
Limited

Can a Florida resident get peptides by telehealth?

Section 456.47, Florida Statutes, defines telehealth as the use of synchronous or asynchronous telecommunications technology by a telehealth provider to provide health care services, including assessment, diagnosis, consultation, treatment, and monitoring of a patient; e-mail messages and fax transmissions do not count. A telehealth provider may use telehealth to perform a patient evaluation, and if the evaluation is sufficient to diagnose and treat the patient the provider need not conduct a physical examination first, as long as the care meets the prevailing professional standard of practice for in-person care. The statute bars telehealth prescribing of Schedule II controlled substances except for narrow cases (psychiatric disorders, hospital inpatients, hospice, nursing home residents); peptides in this database are not scheduled, so GLP-1 and compounded peptide prescriptions are not affected by that limit. Practitioners licensed in another state must hold a Florida out-of-state telehealth provider registration with the applicable Florida board (or the Department of Health where there is no board) before treating Florida patients, and they cannot open a Florida office or provide in-person care under that registration. A practitioner licensed under a multistate health care licensure compact of which Florida is a member also counts as a telehealth provider. The statute does not mention online questionnaires, and the Board of Medicine's former telemedicine rule 64B8-9.0141 was repealed effective October 14, 2019. This record classifies asynchronous prescribing as allowed because the statute defines telehealth to include asynchronous technology and expressly lets a provider use telehealth to perform the patient evaluation. [2] [3] [4]

How does the Florida pharmacy board treat compounding?

Compounding regulator for Florida
BoardFlorida Board of Pharmacy (Florida Department of Health)
Eligible substancesFollows the federal 503A framework

The Board of Pharmacy regulates compounding through chapter 465 (Pharmacy) and rule chapter 64B16-27, including rule 64B16-27.700 (definition of compounding) and rule 64B16-27.797 (standards of practice for sterile compounding). Florida has no separate state bulks list; eligibility of a peptide for compounding follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Two Florida-specific requirements matter for peptide patients: any out-of-state pharmacy that ships a dispensed drug to a Florida patient must register as a nonresident pharmacy under section 465.0156, and any pharmacy or outsourcing facility shipping a compounded sterile product (which covers injectable peptides) into Florida must also hold a nonresident sterile compounding permit under section 465.0158. A telehealth prescription filled by an unregistered mail-order pharmacy is being dispensed unlawfully in Florida even if the prescriber is compliant. [1] [5] [6] [7] [8] [9] [12]

Can you get compounded GLP-1s in Florida?

Regulatory: Compounded GLP-1 limited

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025. Florida patients using telehealth GLP-1 programs should confirm the dispensing pharmacy appears in the Department of Health license lookup as a Florida pharmacy or a registered nonresident pharmacy with a sterile compounding permit. [1] [7] [15]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Florida?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Florida

What you'll actually find in Florida, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [19] [20] [21]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [22]

What Florida has done

PeptideAgent has not found a board or legislative action on peptides in Florida.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [24] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [25] [26] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Florida. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] [3] [4] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Florida Board of Pharmacy (Florida Department of Health); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [23]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [22]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [13] [27] [28]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [23] [29] [30]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [21] [30] [31]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [22] [32] [33] [34] [35] [36]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [22]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [23]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [21]
  • Pharmacy: Is this made for me on a prescription written in my name? [31]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [21] [30]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [21]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Florida?

The Florida Drug and Cosmetic Act (chapter 499) prohibits manufacturing, distributing, or selling adulterated, misbranded, or unapproved new drugs in the state (section 499.005), and requires a Florida drug wholesale or manufacturer permit for anyone distributing prescription drugs. Sellers of "research use only" peptides shipped to Florida consumers for injection are not permitted under chapter 499 and are also subject to federal enforcement. [10] [11] [16]

Peptide-specific notes for Florida

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Florida through telehealth without seeing a doctor in person?

Yes. Florida's telehealth law (section 456.47) allows a licensed or Florida-registered telehealth provider to evaluate you, diagnose, and prescribe using synchronous or asynchronous technology, as long as the care meets the standard of practice. Semaglutide and tirzepatide are not controlled substances, so the Schedule II telehealth restriction does not apply. The statute does not mention online questionnaires. [2] [3]

Can an out-of-state telehealth clinic treat me in Florida?

Only if the practitioner holds a Florida license, a license under a multistate health care licensure compact that Florida has joined, or an out-of-state telehealth provider registration issued by the applicable Florida board (or the Department of Health where there is no board). Registered providers may not open a Florida office or provide in-person services, and the Department of Health can discipline them. Look the provider up in the Department of Health license portal before paying. [2] [3]

Is compounded semaglutide or tirzepatide still available in Florida?

Only in limited, patient specific cases. The federal shortage allowances ended in 2025, so a Florida pharmacy can compound a GLP-1 only when the approved product cannot meet a documented need. Any compounded injectable shipped into Florida must also come from a pharmacy holding a Florida nonresident sterile compounding permit. [7] [15]

How do I check whether a pharmacy is allowed to ship compounded peptides to Florida?

Search the Florida Department of Health license verification for the pharmacy name. An out-of-state pharmacy needs a nonresident pharmacy registration (section 465.0156), and if it ships sterile compounded products such as injectable peptides it also needs a nonresident sterile compounding permit (section 465.0158). If neither appears, the shipment is not lawful in Florida. [1] [6] [7]

Can a Florida pharmacy compound BPC-157 or other unapproved peptides?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). The draft covers only six single peptides (BPC-157, epitalon, KPV, MOTS-c, semax, TB-500); others, such as CJC-1295 and ipamorelin, are not covered. State law still applies: Florida has no separate state bulks list; eligibility of a peptide for compounding follows the federal 503A framework. [8] [13] [14] [17] [18]

Is it legal to buy research peptides online and have them shipped to Florida?

No. Chapter 499 bars the sale and distribution of unapproved or misbranded drugs in Florida and requires permits for anyone distributing prescription drugs. "Research use only" peptides sold for injection are unapproved drugs under both Florida and federal law, and they are not dispensed by a pharmacist. [10] [11] [16]

From the blog

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Florida Board of Pharmacy (Florida Department of Health)
  2. [2]Florida Statutes section 456.47, Use of telehealth to provide services
  3. [3]Florida Department of Health: telehealth and out-of-state telehealth provider registration
  4. [4]Florida Administrative Code rule 64B8-9.0141, Standards for Telemedicine Practice (repealed October 14, 2019), accessed 2026-09-30
  5. [5]Florida Statutes chapter 465, Pharmacy
  6. [6]Florida Statutes section 465.0156, Registration of nonresident pharmacies
  7. [7]Florida Statutes section 465.0158, Nonresident sterile compounding permit
  8. [8]Florida Administrative Code rule 64B16-27.700, Definition of compounding
  9. [9]Florida Administrative Code rule 64B16-27.797, Standards of practice for compounding sterile preparations
  10. [10]Florida Statutes chapter 499, Florida Drug and Cosmetic Act

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Florida?. https://peptideagent.ai/legal/florida
HTML link
<a href="https://peptideagent.ai/legal/florida">Are peptides legal in Florida?</a>, PeptideAgent, updated October 28, 2026.